|
The
NSDUH Report - - Use of Specific Hallucinogens: 2006
- HTML
format (508 compliant version - -also contains the data
table that was used to construct each figure; this data table is not
found in printed or PDF version)
Highlights:
- Hallucinogens
include lysergic acid diethylamide (LSD), phencyclidine (PCP), Ecstasy
(MDMA), Salvia divinorum, ketamine, peyote, mescaline, and psilocybin
(mushrooms). Specific questions on the following hallucinogens were
first collected in SAMHSA's 2006 National Survey on Drug Use and Health:
ketamine, dimethyltryptamine (DMT), alpha-methyltryptamine (AMT), 5-methoxy-diisopropyltryptamine
(5-MeO-DIPT or "Foxy"), and Salvia divinorum.
- Based
on SAMHSA's 2006 National Survey on Drug Use and Health of persons aged
12 or older, 23 million had used LSD, 6.6 million used PCP, 2.3 used
ketamine, 1.8 million used Salvia divinorum and 0.7 million had
used DMT, AMT, or Foxy at least once in their lifetime.
- Among
youth aged 12 to 17, females were more likely than males to have used
Ecstasy in the past year (1.4% vs. 1.0%).
- Among
youth aged 12 to 17, males were more likely than females to have used
Salvia divinorum in the past year (0.9% vs. 0.3%)
- In
2006, young adults aged 18 to 25 were more likely than youths aged 12
to 17 or adults aged 26 or older to be past year users of LSD, Ecstasy,
and Salvia divinorum.
Hallucinogens
Other
drugs
Other
topics
This Short Report,
The NSDUH Report - - Use
of Specific Hallucinogens: 2006, is based on SAMHSA's National Survey
on Drug Use and Health (NSDUH). The survey is conducted by the Office
of Applied Studies (OAS) in the Substance Abuse and Mental Health Services
Administration (SAMHSA). SAMHSA's National Survey
on Drug Use and Health (NSDUH) is the primary source of information
on the prevalence, patterns, and consequences of drug and alcohol use and
abuse and for selected mental health measures in the general U.S. civilian
non institutionalized population, age 12 and older. SAMHSA's
National Survey on Drug Use & Health also provides estimates
for drug use and for selected mental health measures by State. |
